JEFFREY LANE: Open Payments
NPI 1851537690 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 65 payments from 9 companies in 2025. Trend: 2023 $1,364 · 2024 $1,047 · 2025 $1,007
Food & beverage: $1,007
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $542 |
| Indivior Inc. | 11 | $157 |
| PFIZER INC. | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Corium, LLC | 2 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $17 |
| Braeburn Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, SUBLOCADE, QULIPTA, NURTEC ODT, CAPLYTA, XIFAXAN, Azstarys.
Industry payments across IN — which companies pay providers there.
